NS-Adult Spine

Medicine & Life Sciences

1. Spine 100%
2. Systematic Reviews 40%
3. Opioid Analgesics 39%
4. Pathologic Constriction 29%
5. Scoliosis 27%
6. Traumatic Brain Injury 23%
7. Spondylolisthesis 23%
8. Decompression 20%
9. Diskectomy 19%
10. Length of Stay 18%
11. Back Pain 16%
12. Guidelines 15%
13. Narcotics 15%
14. Pain 15%
15. Meta-Analysis 14%
16. Neurosurgeons 14%
17. Psoas Muscles 13%
18. Conservative Treatment 13%
19. Patient Reported Outcome Measures 13%
20. Enhanced Recovery After Surgery 12%
21. Pain Management 12%
22. Blood Transfusion 11%
23. Costs and Cost Analysis 11%
24. Frailty 10%
25. Therapeutics 9%
26. Blood Preservation 9%
27. Erythrocyte Transfusion 9%
28. Insurance 9%
29. Sarcopenia 9%
30. Cauda Equina Syndrome 9%
31. Decompressive Craniectomy 8%
32. Delirium 8%
33. Geriatrics 8%
34. Neurocysticercosis 8%
35. Surgical Wound Infection 8%
36. Trauma Centers 8%
37. Pupil 8%
38. Vertebroplasty 8%
39. Chordoma 8%
40. Spinal Cord Stimulation 8%
41. Pathology 8%
42. Three-Dimensional Printing 7%
43. Intervertebral Disc Displacement 7%
44. Biomarkers 7%
45. Neurosurgery 7%
46. Sacrum 7%
47. Intractable Pain 7%
48. Laryngoscopes 7%
49. Neoplasm Metastasis 7%
50. Stress Fractures 7%
51. Gliosis 7%
52. African Americans 7%
53. Unconsciousness 7%
54. Subarachnoid Hemorrhage 7%
55. Minimally Invasive Surgical Procedures 6%
56. Astrocytoma 6%
57. Triage 6%
58. Radiosurgery 6%
59. Morbidity 6%
60. Anatomy 6%
61. Cerebral Hemorrhage 6%
62. Databases 6%
63. Wounds and Injuries 6%
64. Genetic Markers 6%
65. varespladib methyl 6%
66. Anesthesiologists 6%
67. Injections 6%
68. Vertebral Artery 6%
69. Retrospective Studies 6%
70. Obesity 5%
71. Population 5%
72. Nervous System 5%
73. Intubation 5%
74. Spinal Cord 5%
75. Steroids 5%
76. Pancreatic Neoplasms 5%
77. PubMed 5%
78. Hematoma 5%
79. Sex Characteristics 5%
80. Brain Neoplasms 5%
81. Lead 5%
82. Personality 5%
83. Endoscopy 5%
84. Analgesics 5%
85. Postoperative Complications 5%
86. Mortality 5%
87. Single Nucleotide Polymorphism 5%
88. Anxiety 5%